Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Current Assets (2018 - 2025)

Neurogene (NGNE) has disclosed Current Assets for 5 consecutive years, with $279.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Assets rose 75.3% year-over-year to $279.0 million, compared with a TTM value of $279.0 million through Jun 2025, up 75.3%, and an annual FY2024 reading of $315.9 million, changed N/A over the prior year.
  • Current Assets was $279.0 million for Q2 2025 at Neurogene, down from $296.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $315.9 million in Q4 2024 and bottomed at $159.1 million in Q2 2024.